Nick takes a hands-on approach to running Inpharmation’s modeling and analytics department. He is involved in every project from the beginning, through to delivery, and beyond. It is Nick who decides who in Inpharmation has the best strategic and technical knowledge to lead each project, and then chooses the best people to work within that team. Clients value the fact that Nick knows their projects intimately and is always available to speak to them.
His consulting experience is enormously wide. He has worked with all the top 20 pharma companies and the majority of the top 50. He has worked in all major therapy areas, all major HTA systems, and at all stages of the pharmaceutical lifecycle. He has worked in pricing, market access, demand forecasting, market research, behavior-based pricing, and international reference pricing.
Nick was instrumental in developing Inpharmation’s market leading international referencing software. He was one of the first people to realize, way back in 2008, that financial crises lead to pharmaceutical price cuts which cascade through the international referencing system. He has successfully guided many clients accordingly.
Nick is a sought-after speaker on pricing, market access, and international reference pricing. He delivers forecasting and pricing training courses. He co-authors papers with clients.
Nick has degrees in Molecular and Cellular Biochemistry from the University of Oxford.
He joined Inpharmation’s Board of Directors in 2021.